Peter Attia· MD
in this very first study in 2014 we brought patients back a year later and revaccinated them to see if the improvement in immunologic function persisted and it did not
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in this very first study in 2014 we brought patients back a year later and revaccinated them to see if the improvement in immunologic function persisted and it did not
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.